Connect your AI

Regeneron Pharmaceuticals REGN Income Tax

Income Tax at other companies

Merck & Co.MRK

$709M-13.3%

AmgenAMGN

$265M+9.1%

Nektar TherapeuticsNKTR

$64K+23.1%

GlaukosGKOS

$484K+48.5%

EyePoint, Inc. EYPT

-$50K—

Arcus BiosciencesRCUS

$0—

Other financials

Income statement

Revenue$3.6B+19.0%

Operating income$642.9M+8.7%

Net income$727.2M-10.1%

EPS (diluted)$6.75-7.2%

Balance sheet

Cash & equivalents$3.0B-4.0%

Total debt$2.7B+0.1%

Total equity$31.4B+6.9%

Total assets$40.9B+8.9%

Cash flow

Operating cash flow$1.1B+3.2%

CapEx$230.6M+0.6%

Free cash flow$848.3M+4.0%

Valuation

Market cap$65.37B+16.2%

Enterprise value$65.11B+14.3%

P/E14.8×+2.2×

P/S4.4×+0.4×

Profitability

Gross margin93.9%—

Operating margin24.3%-2.9pp

Net margin29.6%-2.3pp

FCF margin27.6%+5.5pp

Returns & leverage

Return on equity14.5%-1.4pp

Debt / equity0.1×0.0×

Current ratio3.6×-1.4×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regeneron Pharmaceuticals's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Regeneron Pharmaceuticals's income tax?: Regeneron Pharmaceuticals (REGN) reported income tax of $104M in Q1 2026.
How has Regeneron Pharmaceuticals's income tax changed year-over-year?: Regeneron Pharmaceuticals's income tax increased by 8.0% year-over-year, from $96.3M to $104M.
What is the long-term trend for Regeneron Pharmaceuticals's income tax?: Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's income tax has grown at a -12.7% compound annual growth rate (CAGR), from $1.25B to $725.8M.
What does income tax mean?: Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.